Insights

Gathering insights about Inventiva…

Similar companies to Inventiva

Inventiva Tech Stack

Inventiva uses 5 technology products and services including Google Hosted Libraries, Google Fonts API, jQuery, and more. Explore Inventiva's tech stack below.

Google Hosted Libraries
Content Delivery Network
Google Fonts API
Font Scripts
jQuery
Javascript Libraries
Webflow
Page Builders
reCAPTCHA
Security

Media & News

Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Rating of “Moderate Buy” by Brokerages
Inventiva S.A. Sponsored ADR (NASDAQ: IVA - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven ratings firms that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, five have given a buy rating and one has issued a strong buy
Dec 30, 2025 | www.defenseworld.net
Inventiva reports 2025 Third Quarter Financial Information¹
Daix (France), New York City, (New York, United States), November 21, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis ("MASH"), today reported its cash position as of September 30, 2025 and its revenues for the first nine months of 2025.
Nov 21, 2025 | www.globenewswire.com
Inventiva announces full exercise of Underwriters' Option, bringing proceeds of Offering to approximately $172.5M
Daix (France), New York City (New York, United States), November 17, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis ("MASH"), today announced that the underwriters of the previously announced public offering in the United States (the "Offering") of 38,961,038 American Depositary Shares ("ADSs"), each representing one ordinary share of the Company with a nominal value of €0.01, have exercised in full their option (the "Underwriters' Option") to purchase 5,844,155 additional ADSs (the "Additional ADSs"). The additional ADSs are expected to be delivered on November 18, 2025.
Nov 17, 2025 | www.globenewswire.com
Wall Street Week Ahead
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Nov 16, 2025 | seekingalpha.com
Inventiva announces trading resumption of its ordinary shares on Euronext Paris
Daix (France), New York City (New York, United States), November 13, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis ("MASH"), announced the trading resumption of its ordinary shares on the regulated market of Euronext in Paris as from 4:30 p.m. (CET).
Nov 13, 2025 | www.globenewswire.com
Inventiva announces pricing of upsized public offering of approximately $150M of American Depositary Shares
Daix (France), New York City (New York, United States), November 13, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis ("MASH"), today announced the pricing of its previously announced underwritten public offering, in the United States only, of 38,961,038 new American Depositary Shares ("ADSs"), each representing one new ordinary share of the Company with a nominal value of €0.01, at an offering price of $3.85 per ADS (the "Offering"). Settlement and delivery of the Offering is expected on November 17, 2025, subject to the satisfaction of customary closing conditions.
Nov 13, 2025 | www.globenewswire.com
Inventiva announces temporary trading halt of its ordinary shares on Euronext Paris
Daix (France), New York City (New York, United States), November 13, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis ("MASH"), announced today that trading of its ordinary shares on the regulated market of Euronext Paris ("Euronext Paris") will be temporarily halted, at the Company's request, from the opening of the market at 9:00 a.m. (CET). This trading halt takes place in the context of the previously announced public offering by the Company in the United States only of new American Depositary Shares (the "ADSs"), each representing one new ordinary share of the Company with a nominal value of €0.01 (the "Offering"), in order to allow for the confirmation of allocations to investors and the announcement of the pricing of the Offering.
Nov 13, 2025 | www.globenewswire.com

Inventiva's Email Address Formats

Inventiva uses at least 1 format(s):

Inventiva Email Formats	Example	Percentage
First@inventiva.com	John@inventiva.com	33%
LFirst@inventiva.com	DJohn@inventiva.com	23%
FLast@inventiva.com	JDoe@inventiva.com	11%
First@inventiva.com	John@inventiva.com	33%

Frequently Asked Questions

What is Inventiva's phone number?

You can contact Inventiva's main corporate office by phone at

+1-830-438-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Inventiva's stock symbol?

Inventiva is a publicly traded company; the company's stock symbol is IVA.

What is Inventiva's official website and social media links?

Inventiva's official website is inventiva.com and has social profiles on LinkedIn.

How much revenue does Inventiva generate?

As of December 2025, Inventiva's annual revenue is estimated to be $1.6M.

What is Inventiva's SIC code NAICS code?

Inventiva's SIC code is 8742 - Management Consulting Services NAICS code is 541613 - Marketing Consulting Services.

How many employees does Inventiva have currently?

As of December 2025, Inventiva has approximately 45 employees across 4 continents, including South AmericaNorth AmericaAsia. Key team members include Chief Strategy Officer (cso): E. G.Creative Services Director: E. G.Principal: H. G.. Explore Inventiva's employee directory with LeadIQ.

What industry does Inventiva belong to?

Inventiva operates in the Advertising Services industry.

What technology does Inventiva use?

Inventiva's tech stack includes Google Hosted LibrariesGoogle Fonts APIjQueryWebflowreCAPTCHA.

What is Inventiva's email format?

Inventiva's email format typically follows the pattern of First@inventiva.com. Find more Inventiva email formats with LeadIQ.

When was Inventiva founded?

Inventiva was founded in 1990.

Inventiva

Q: What is Inventiva's official website and social media links?

Inventiva's official website is inventiva.com. Inventiva has social profiles on LinkedIn.

Q: How many employees does Inventiva have currently?

Inventiva has approximately 45 employees.

Q: What technology does Inventiva use?

Inventiva's tech stack includes Webflow, Google Fonts API, Google Hosted Libraries, jQuery, reCAPTCHA.

Advertising ServicesTexas, United States11-50 Employees

Award winning multicultural marketing, advertising and consulting firm.

Company Overview

Phone number: +1-830-438-****
Website: inventiva.com
SIC Code: 8742 - Management Consulting Services
Stock Symbol: IVA
NAICS Code: 541613 - Marketing Consulting Services
Founded: 1990
Employees: 11-50

Media & News

Funding & Financials

$50M$100M
Inventiva's revenue is estimated to be in the range of $50M$100M

Funding & Financials

$50M$100M
Inventiva's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Inventiva

Medpace

Charles River Laboratories

Syneos Health

Covance

IQVIA

药明康德

Labcorp Drug Development

Spero Therapeutics

Parexel

Inventiva Tech Stack

Media & News

Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Rating of “Moderate Buy” by Brokerages

Inventiva reports 2025 Third Quarter Financial Information¹

Inventiva announces full exercise of Underwriters' Option, bringing proceeds of Offering to approximately $172.5M

Wall Street Week Ahead

Inventiva announces trading resumption of its ordinary shares on Euronext Paris

Inventiva announces pricing of upsized public offering of approximately $150M of American Depositary Shares

Inventiva announces temporary trading halt of its ordinary shares on Euronext Paris

Inventiva's Email Address Formats

Frequently Asked Questions

What is Inventiva's phone number?

What is Inventiva's stock symbol?

What is Inventiva's official website and social media links?

How much revenue does Inventiva generate?

What is Inventiva's SIC code NAICS code?

How many employees does Inventiva have currently?

What industry does Inventiva belong to?

What technology does Inventiva use?

What is Inventiva's email format?

When was Inventiva founded?

Inventiva

Company Overview

Media & News

Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Rating of “Moderate Buy” by Brokerages

Inventiva reports 2025 Third Quarter Financial Information¹

Inventiva announces full exercise of Underwriters' Option, bringing proceeds of Offering to approximately $172.5M

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?